137 related articles for article (PubMed ID: 21244575)
1. Microarray analysis identifies versican and CD9 as potent prognostic markers in gastric gastrointestinal stromal tumors.
Setoguchi T; Kikuchi H; Yamamoto M; Baba M; Ohta M; Kamiya K; Tanaka T; Baba S; Goto-Inoue N; Setou M; Sasaki T; Mori H; Sugimura H; Konno H
Cancer Sci; 2011 Apr; 102(4):883-9. PubMed ID: 21244575
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical and genetic features of gastric and metastatic liver gastrointestinal stromal tumors: sequential analyses.
Kikuchi H; Yamashita K; Kawabata T; Yamamoto M; Hiramatsu Y; Kondo K; Baba M; Ohta M; Kamiya K; Tanaka T; Suzuki S; Kitagawa K; Kitagawa M; Sugimura H; Konno H
Cancer Sci; 2006 Feb; 97(2):127-32. PubMed ID: 16441423
[TBL] [Abstract][Full Text] [Related]
4. Kit K641E oncogene up-regulates Sprouty homolog 4 and trophoblast glycoprotein in interstitial cells of Cajal in a murine model of gastrointestinal stromal tumours.
Gromova P; Ralea S; Lefort A; Libert F; Rubin BP; Erneux C; Vanderwinden JM
J Cell Mol Med; 2009 Aug; 13(8A):1536-48. PubMed ID: 19453770
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST).
Kou Y; Zhao Y; Bao C; Wang Q
Cell Biochem Biophys; 2015 Jun; 72(2):571-8. PubMed ID: 25586720
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of
Yuan J; Kihara T; Kimura N; Hashikura Y; Ohkouchi M; Isozaki K; Takahashi T; Nishida T; Ito A; Hirota S
Pathol Oncol Res; 2021; 27():602008. PubMed ID: 34257559
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
9. Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors.
Haller F; Happel N; Schulten HJ; von Heydebreck A; Schwager S; Armbrust T; Langer C; Gunawan B; Doenecke D; Füzesi L
Mod Pathol; 2007 Oct; 20(10):1103-11. PubMed ID: 17673922
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
[TBL] [Abstract][Full Text] [Related]
11. KIT mutation in a naïve succinate dehydrogenase-deficient gastric GIST.
Brcic I; Kashofer K; Skone D; Liegl-Atzwanger B
Genes Chromosomes Cancer; 2019 Nov; 58(11):798-803. PubMed ID: 31124195
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival.
Haller F; Cortis J; Helfrich J; Cameron S; Schüler P; Schwager S; Gunawan B; Füzesi L; Agaimy A
Mod Pathol; 2011 Feb; 24(2):248-55. PubMed ID: 20834236
[TBL] [Abstract][Full Text] [Related]
13. Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression.
Ostrowski J; Polkowski M; Paziewska A; Skrzypczak M; Goryca K; Rubel T; Kokoszyñska K; Rutkowski P; Nowecki ZI; Vel Dobosz AJ; Jarosz D; Ruka W; Wyrwicz LS
BMC Cancer; 2009 Nov; 9():413. PubMed ID: 19943934
[TBL] [Abstract][Full Text] [Related]
14. Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors.
Kikuchi H; Yamamoto M; Hiramatsu Y; Baba M; Ohta M; Kamiya K; Tanaka T; Suzuki S; Sugimura H; Kitagawa M; Kanai T; Kitayama Y; Kanda T; Nishikura K; Konno H
Cancer Sci; 2007 Nov; 98(11):1734-9. PubMed ID: 17894554
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
[TBL] [Abstract][Full Text] [Related]
16. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of gastrointestinal stromal tumors and gastric adenocarcinomas.
Yan Y; Li Z; Liu Y; Zhang L; Li J; Ji J
Tumour Biol; 2013 Apr; 34(2):919-27. PubMed ID: 23283817
[TBL] [Abstract][Full Text] [Related]
18. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.
Agaimy A; Wünsch PH; Hofstaedter F; Blaszyk H; Rümmele P; Gaumann A; Dietmaier W; Hartmann A
Am J Surg Pathol; 2007 Jan; 31(1):113-20. PubMed ID: 17197927
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of Cajal.
Gromova P; Rubin BP; Thys A; Erneux C; Vanderwinden JM
PLoS One; 2011 Feb; 6(2):e14710. PubMed ID: 21364741
[TBL] [Abstract][Full Text] [Related]
20. Versican expression in tumor epithelial cells is correlated with a good prognosis in gastric cancer.
Kim NS; Lee HH; Jung CK; Jeon HM
Anticancer Res; 2014 Oct; 34(10):5613-9. PubMed ID: 25275064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
